Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone

Madeleine Lachance; Jean Bernard; Aubert Lavoie; Éric Gagné; Pierre-Olivier Grenier

doi:10.1016/j.jdcr.2022.01.022

Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone

JAAD Case Rep. 2022 Feb 9:22:11-13. doi: 10.1016/j.jdcr.2022.01.022. eCollection 2022 Apr.

Authors

Madeleine Lachance¹, Jean Bernard¹, Aubert Lavoie², Éric Gagné³, Pierre-Olivier Grenier¹

Affiliations

¹ Department of Dermatology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada.
² Department of Immunology and Allergology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada.
³ Department of Pathology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada.

No abstract available

Keywords: HES, hypereosinophilic syndromes; IL, interleukin; Wells syndrome; anti–IL-5; eosinophilic dermatosis; hypereosinophilic syndrome; mepolizumab.

Publication types

Case Reports